INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm – Fate Therapeutics
Los Angeles, California–(Newsfile Corp. – March 7, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fate Therapeutics, Inc. (“Fate” or “the Company”) FATE for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the US Securities and Exchange Commission.
Investors who purchased the Company’s securities between April 2, 2020 and January 5, 2023, inclusive (the ”Class Period”), are encouraged to contact the firm before March 22, 2023.
If you are a shareholder who has suffered a loss, click here


/cloudfront-us-east-1.images.arcpublishing.com/gray/G5M5MO5M3MMRSJPCYAMWAGHPJA.jpg)

/cloudfront-us-east-1.images.arcpublishing.com/gray/G5M5MO5M3MMRSJPCYAMWAGHPJA.jpg)